Maximising AI’s impact in drug discovery requires practical tools that empower scientists. It also necessitates a focus on the implementation of proven algorithms and organisational change. Using case study examples from our StarDrop and Cerella platforms we show how AI’s value can be demonstrated.

Matthew Segall, Chief Executive Officer, Optibrium